Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy.

MLA

Engelke, Udo F. H., et al. “Untargeted Metabolomics and Infrared Ion Spectroscopy Identify Biomarkers for Pyridoxine-Dependent Epilepsy.” Journal of Clinical Investigation, vol. 131, no. 15, Aug. 2021, pp. 1–15. EBSCOhost, https://doi.org/10.1172/JCI148272.

APA

Engelke, U. F. H., van Outersterp, R. E., Merx, J., van Geenen, F. A. M. G., van Rooij, A., Berden, G., Huigen, M. C. D. G., Kluijtmans, L. A. J., Peters, T. M. A., Al-Shekaili, H. H., Leavitt, B. R., de Vrieze, E., Broekman, S., van Wijk, E., Tseng, L. A., Kulkarni, P., Rutjes, F. P. J. T., Mecinović, J., Struys, E. A., & Jansen, L. A. (2021). Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy. Journal of Clinical Investigation, 131(15), 1–15. https://doi.org/10.1172/JCI148272

Chicago

Engelke, Udo F. H., Rianne E. van Outersterp, Jona Merx, Fred A. M. G. van Geenen, Arno van Rooij, Giel Berden, Marleen C. D. G. Huigen, et al. 2021. “Untargeted Metabolomics and Infrared Ion Spectroscopy Identify Biomarkers for Pyridoxine-Dependent Epilepsy.” Journal of Clinical Investigation 131 (15): 1–15. doi:10.1172/JCI148272.